AUSTIN, Texas, Sept. 9, 2014 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTCQB:BICX), a leader in addiction treatment programs, is now available. The interview can be heard http://smallcapvoice.com/blog/8-14-14-smallcapvoice-interview-with-biocorrx-inc-bicx.
In the interview Kent Emry stated, "I think the exciting thing here is traditionally the Company had made money and kept ourselves afloat by selling licenses. However, our goal has always been to get those licensees to be opening clinics. So, eventually we could be making our revenue from actually selling the program. That is true cash flow and that means we are actually growing as a company and what it is that we set out to do: Sell programs, change people's lives, and help addicts and alcoholics. Q2 of this year was the very first time in the history of the Company that we are cash flow positive just from program sales. This ensures that we are growing in a strong sustainable way for years to come."
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About BioCorRx, Inc.
BioCorRx, Inc. (BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit www.BICXCorp.com
Visit BioCorRx, Inc.'s new investor relations website www.BICXcorp.com to receive the most up-to-date company information.
Click here to view Recent National Television Media on the BioCorRx YouTube Channel
Click here for the company Facebook page for more stories and media coverage
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.